Discover
EW
Edwards Lifesciences Corporation
93.23
1 x 93.30
1 x 93.34
bid
ask
+
1.20
1.30%
12:35 PM
timesize
| Ytd | 9.36% | |
| 1y | 19.28% |
91.97
day range
93.75
72.65
52 week range
95.18
| Open | 92.03 | Prev Close | 92.03 | Low | 91.97 | High | 93.75 | Mkt Cap | 53.70B |
| Vol | 1.14M | Avg Vol | 4.98M | EPS | 2.70 | P/E | 34.54 | Forward P/E | 26.58 |
| Beta | 0.85 | Short Ratio | 2.32 | Inst. Own | 93.53% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-23 | 50-d Avg | 88.12 | 200-d Avg | 84.15 | 1yr Est | 100.96 |
| Income Statement | |||
| Total Revenue | 1.74B | ||
| Revenues (USD) | 1.74B | ||
| Cost of Revenue | 392.40M | ||
| Gross Profit | 1.35B | ||
| Operating Expenses | 875.40M | ||
| Research and Development Expense | 278.90M | ||
| Selling, General and Administrative Expense | 561.20M | ||
| Operating Income | 473.20M | ||
| Income Tax Expense | 278.40M | ||
| Net Income | 241.90M | ||
| Net Income Common Stock | 241.90M | ||
| Net Income Common Stock (USD) | 241.90M | ||
| Consolidated Income | 241.40M | ||
| Net Income to Non-Controlling Interests | -500.00K | ||
| Earnings per Basic Share | 0.42 | ||
| Earnings per Basic Share (USD) | 0.42 | ||
| Earnings per Diluted Share | 0.42 | ||
| Earning Before Interest & Taxes (EBIT) | 520.30M | ||
| Earning Before Interest & Taxes (USD) | 520.30M | ||
| Weighted Average Shares | 576.40M | ||
| Weighted Average Shares Diluted | 577.60M | ||
| Balance Sheet | |||
| Cash and Equivalents | 2.91B | ||
| Cash and Equivalents (USD) | 2.91B | ||
| Investments | 1.59B | ||
| Investments Current | 1.35B | ||
| Investments Non-Current | 244.10M | ||
| Trade and Non-Trade Receivables | 955.70M | ||
| Current Assets | 6.82B | ||
| Property, Plant & Equipment Net | 1.94B | ||
| Total Assets | 13.87B | ||
| Debt Current | 24.10M | ||
| Total Debt | 704.40M | ||
| Current Liabilities | 1.51B | ||
| Debt Non-Current | 680.30M | ||
| Total Liabilities | 3.14B | ||
| Accumulated Retained Earnings (Deficit) | 14.86B | ||
| Accumulated Other Comprehensive Income | -214.60M | ||
| Shareholders Equity | 10.62B | ||
| Shareholders Equity (USD) | 10.62B | ||
| Assets Non-Current | 7.05B | ||
| Total Debt (USD) | 704.40M | ||
| Goodwill and Intangible Assets | 3.33B | ||
| Inventory | 1.13B | ||
| Liabilities Non-Current | 1.63B | ||
| Trade and Non-Trade Payables | 1.48B | ||
| Tax Assets | 911.80M | ||
| Tax Liabilities | 572.20M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 49.30M | ||
| Net Cash Flow from Financing | -300.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 462.20M | ||
| Capital Expenditure | -66.90M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -5.70M | ||
| Issuance (Purchase) of Equity Shares | -99.50M | ||
| Net Cash Flow from Investing | -193.20M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -113.60M | ||
| Net Cash Flow from Operations | 651.90M | ||
| Effect of Exchange Rate Changes on Cash | 3.80M | ||
| Share Based Compensation | 42.20M | ||